Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature

Cinzia Volonté , Rafael Franco

Exploration of Neuroprotective Therapy ›› 2023, Vol. 3 ›› Issue (6) : 429 -434.

PDF (1229KB)
Exploration of Neuroprotective Therapy ›› 2023, Vol. 3 ›› Issue (6) :429 -434. DOI: 10.37349/ent.2023.00059
Commentary
research-article
Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature
Author information +
History +
PDF (1229KB)

Keywords

Purinergic receptors / purinergic signature / chunking theory / engram / information unit / heteromer

Cite this article

Download citation ▾
Cinzia Volonté, Rafael Franco. Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature. Exploration of Neuroprotective Therapy, 2023, 3 (6) : 429-434 DOI:10.37349/ent.2023.00059

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Burnstock G. Introduction to purinergic signalling in the brain. In: Barańska J, editor. Glioma signaling. Cham: Springer; 2020. pp. 1-12.

[2]

Burnstock G. Purine and purinergic receptors. Brain Neurosci Adv. 2018; 2: 2398212818817494.

[3]

Burnstock G. Purinergic signalling: therapeutic developments. Front Pharmacol. 2017; 8: 661.

[4]

Burnstock G, Campbell G, Satchell D, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol. 1997; 120: 337-57.

[5]

Volonté C, Amadio S, D’Ambrosi N, Colpi M, Burnstock G. P2 receptor web: complexity and fine-tuning. Pharmacol Ther. 2006; 112: 264-80.

[6]

Burnstock G. Introduction to purinergic signaling. In: Pelegrín P, editor. Purinergic signaling. New York (NY): Humana; 2020. pp. 1-15.

[7]

Hervás C, Pérez-Sen R, Miras-Portugal MT. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells. J Neurosci Res. 2003; 73: 384-99.

[8]

Amadio S, Montilli C, Picconi B, Calabresi P, Volonté C. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: an immunohistological study. Purinergic Signal. 2007; 3: 389-98.

[9]

D’Ambrosi N, Iafrate M, Saba E, Rosa P, Volonté C. Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems. Biochim Biophys Acta. 2007; 1768: 1592-9.

[10]

Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, et al. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm (Vienna). 2007; 114: 49-75.

[11]

Volonté C, Amadio S, D’Ambrosi N. Receptor webs: Can the chunking theory tell us more about it? Brain Res Rev. 2008; 59: 1-8.

[12]

Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1994; 101: 343-52.

[13]

Zoli M, Guidolin D, Fuxe K, Agnati LF. The receptor mosaic hypothesis of the engram: possible relevance of Boolean network modeling. Int J Neural Syst. 1996; 7: 363-8.

[14]

Agnati LF, Ferré S, Leo G, Lluis C, Canela EI, Franco R, et al. On the molecular basis of the receptor mosaic hypothesis of the engram. Cell Mol Neurobiol. 2004; 24: 501-16.

[15]

Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, et al. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev. 2008; 58: 415-52.

[16]

D’Ambrosi N, Volonté C. Metabotropic purinergic receptors in lipid membrane microdomains. Curr Med Chem. 2013; 20: 56-63.

[17]

Volonté C, D’Ambrosi N. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J. 2009; 276: 318-29.

[18]

Kittner H, Franke H, Fischer W, Schultheis N, Krügel U, Illes P. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology. 2003; 28: 435-44.

[19]

Kawamura M, Gachet C, Inoue K, Kato F. Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice. J Neurosci. 2004; 24: 10835-45.

[20]

Guzman SJ, Gerevich Z, Hengstler JG, Illes P, Kleemann W. P2Y1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex. Synapse. 2005; 57: 235-8.

[21]

Carvalho GB, Mulpuri Y, Damasio A, Spigelman I. A role for the P2Y1 receptor in nonsynaptic cross-depolarization in the rat dorsal root ganglia. Neuroscience. 2019; 423: 98-108.

[22]

Thu Le HT, Murugesan A, Candeias NR, Yli-Harja O, Kandhavelu M. Functional characterization of HIC, a P2Y1 agonist, as a p53 stabilizer for prostate cancer cell death induction. Future Med Chem. 2021; 13: 1845-64.

[23]

Cho JM, Park SK, Kwon OS, Taylor La Salle D, Cerbie J, Fermoyle CC, et al. Activating P2Y1 receptors improves function in arteries with repressed autophagy. Cardiovasc Res. 2023; 119: 252-67.

[24]

Lillo A, Martínez-Pinilla E, Reyes-Resina I, Navarro G, Franco R. Adenosine A2A and A3 receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling. Int J Mol Sci. 2020; 21: 5070.

[25]

Franco R, Rivas-Santisteban R, Casanovas M, Lillo A, Saura CA, Navarro G. Adenosine A2A receptor antagonists affects NMDA glutamate receptor function. Potential to address neurodegeneration in Alzheimer’s disease. Cells. 2020; 9: 1075.

[26]

Franco R, Reyes-Resina I, Aguinaga D, Lillo A, Jiménez J, Raïch I, et al. Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists. Glia. 2019; 67: 2410-23.

[27]

Cristóvão-Ferreira S, Navarro G, Brugarolas M, Pérez-Capote K, Vaz SH, Fattorini G, et al. A1R-A2AR heteromers coupled to Gs and Gi/o proteins modulate GABA transport into astrocytes. Purinergic Signal. 2013; 9: 433-49.

[28]

Arendt D, Musser JM, Baker CVH, Bergman A, Cepko C, Erwin DH, et al. The origin and evolution of cell types. Nat Rev Genet. 2016; 17: 744-57.

[29]

Xia B, Yanai I. A periodic table of cell types. Development. 2019; 146: dev169854.

PDF (1229KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉